Spectranetics
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Spectranetics beat expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded and GAAP earnings per share grew.
Gross margins contracted, operating margins were steady, net margins grew.
Revenue details
Spectranetics tallied revenue of $35.2 million. The six analysts polled by S&P Capital IQ expected revenue of $34.5 million on the same basis. GAAP reported sales were 9.7% higher than the prior-year quarter's $32.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $0.03. The six earnings estimates compiled by S&P Capital IQ predicted $0.03 per share. GAAP EPS of $0.03 for Q3 were much higher than the prior-year quarter's $0.00 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 72.7%, 30 basis points worse than the prior-year quarter. Operating margin was 3.1%, about the same as the prior-year quarter. Net margin was 2.6%, 230 basis points better than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $35.9 million. On the bottom line, the average EPS estimate is $0.04.
Next year's average estimate for revenue is $138.8 million. The average EPS estimate is $0.10.
Investor sentiment
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 156 members out of 174 rating the stock outperform, and 18 members rating it underperform. Among 40 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give Spectranetics a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Spectranetics is outperform, with an average price target of $14.86.
- Add Spectranetics to My Watchlist.
